MedTechnology
By
Is Viz.ai Transforming Medical Diagnostics and Acute Care with AI, Driving Global Adoption and Strategic Health System Collaboration?
Executive Summary Viz.ai, a leader in AI‑enabled clinical diagnostics and workflow orchestration, is reshaping how acute care conditions—especially…
Is NVIDIA Powering the AI Revolution in Medical Diagnostics as Healthcare Partners Commit to Next‑Gen Intelligence Platforms?
Executive Summary NVIDIA, the global leader in accelerated computing and AI infrastructure, is increasingly at the core of…
Does BioMark’s 2025 Corporate Update Mark the Shift from Clinical Validation to Commercial-Scale Growth in Lung Cancer Diagnostics?
Executive Summary BioMark’s 2025 corporate update marks a decisive inflection point as the company completes a landmark lung…
Can AI-Automated Hematology Redefine Laboratory Diagnostics? WORK Medical Secures Manufacturing Approval for Class II Blood Cell Analyzer
Hangzhou, China – December 2025 — WORK Medical Technology Group LTD (Nasdaq: WOK) today announced that its subsidiary,…
Is China Outpacing the Global Biopharma Cycle? Innovation and Deal Momentum Accelerate
23 January 2026 Executive Summary China’s biopharma sector is continuing to advance at remarkable speed, with recent analyses…
Is China Becoming a Power Center for AI-Led Drug Discovery? Insilico Medicine Strikes $66 Million NLRP3 Licensing Deal
23 January 2026 Executive Summary Artificial-intelligence-driven drug developer Insilico Medicine has entered into a $66 million licensing agreement…
